Treatment study for enterococcus faecalis bloodstream infection
Part of Infections clinical trials.
This trial looks at how well certain penicillin-type antibiotics work for treating a bloodstream infection caused by a bacterium called Enterococcus faecalis. It may help doctors know which treatment is best for patients with this infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have had a positive blood test for Enterococcus faecalis between January 2017 and December 2023
- You were treated with penicillin for 7 days or more
- Your treatment included amoxicillin or piperacillin-tazobactam (penicillin drugs)
- The bacterium was not resistant to amoxicillin
- You did not have another serious infection (endocarditis) in the first 7 days of treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects health information from adults with bloodstream infections to learn more about how these infections are managed and to find better ways to treat them. If you join, your medical data may be used for research, and you might be invited to join a sub-study about treatments.
This study looks at new ways to fight antibiotic-resistant bacteria in people with certain common infections. It may help by testing approaches tailored to the specific germs found in your urine, lungs, or deeper infections.
This study looks at whether using two or more antibiotics together works better than one alone for a specific type of blood infection caused by Enterococcus faecalis bacteria. The goal is to find the safest and most effective way to treat this infection and improve outcomes for patients.
This trial tests whether piperacillin-tazobactam works as well as meropenem to treat bloodstream infections caused by certain E. coli or Klebsiella germs that resist common cephalosporin antibiotics. It may help you avoid a “bigger” antibiotic if the study drug is equally effective.
This study looks at how doctors can best manage antibiotics for a common type of blood infection (caused by Enterobacterales bacteria like E. coli). If you join, your treatment will be carefully guided to make sure you get the right antibiotics at the right time, which may help you recover faster and prevent antibiotic resistance.
This trial tests whether the antibiotic cefotetan works as well as current standard treatments for E. coli bloodstream infections that start in the urinary tract. If you qualify, you may receive either cefotetan or the usual antibiotic therapy.
Hear when a new Enterococcus Faecalis Bacteremia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.